Absci Corporation (NASDAQ:ABSI) is one of the best biotech penny stocks to buy according to analysts. On December 11, Absci ...

Additionally, on December 23, Invivyd announced two major regulatory and clinical milestones for VYD2311, which is its ...

And for patients facing extreme limitations to mobility, or who live vast distances from hospitals and clinics, mobile ...

A redesigned immune-activating cancer drug has produced striking early results in a small clinical trial, shrinking tumors ...

Two phase III studies of setrusumab, Orbit and Cosmic, for treating brittle bones have failed and left the developers floundering on Wall Street. Neither of Ultragenyx Pharmaceutical Inc. and Mereo ...

High levels of the periodontal bacterium Fusobacterium nucleatum may be associated with more severe disability in people with multiple sclerosis.

Genmab will stop development of its experimental antibody therapy to treat cancer that was in late-stage trials, the Danish ...

Increasing evidence suggests that the severe gum disease, periodontitis, may contribute to central nervous system disorders ...

A new study explains how pancreatic tumors use a sugar coating to hide from the immune system and shows that a newly ...

The acquired von Willebrand syndrome (AVWS) is a rare bleeding disorder with laboratory findings similar to those of inherited von Willebrand disease. Researchers from the Nara Medical University and ...

Researchers at Texas Biologics at The University of Texas at Austin recently made a discovery that they believe could ...

Lifordi Immunotherapeutics and other biotechnology companies are using antibodies to precisely target drugs in the body.